NCT06400485
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06400485
Title AMT-676 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Multitude Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Carolina Biooncology Institute NOT_YET_RECRUITING Huntersville North Carolina 28078 American Samoa Details
John Hopkins Sidney Kimmel Comprehensive Cancer Center NOT_YET_RECRUITING Philadelphia Pennsylvania 19107 American Samoa Details
South Texas Accelerated Research Therapeutics (start) San Antonio NOT_YET_RECRUITING San Antonio Texas American Samoa Details
SCIENTIA Clinical Research Ltd RECRUITING Randwick New South Wales Australia Details
Macquarie University Hospital RECRUITING Macquarie New South wWales Australia Details
Gallipoli Medical Research Foundation RECRUITING Greenslopes Queensland Australia Details
Cabrini Hospital RECRUITING Melbourne Victoria Australia Details
Linear Research RECRUITING Nedlands Western Australia Australia Details
Fujian Provincial Cancer Hospital NOT_YET_RECRUITING Fuzhou Fujian 350014 China Details
Sun Yat-sen University Cancer Center NOT_YET_RECRUITING Guangzhou Guangdong 510060 China Details
Shanghai East Hospital NOT_YET_RECRUITING Shanghai Shanghai Municipality 200000 China Details
Sichuan Provincial People's Hospital NOT_YET_RECRUITING Chengdu Sichuan 610000 China Details
Sir Run Run Shaw Hospital NOT_YET_RECRUITING Hangzhou Zhejiang 310016 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field